Skip to main navigation Skip to main content

Page translation not available

This page is not available in the language that has been selected and will appear in English.

Lunar-2

LUNAR-2: Pivotal, Randomized, Open-Label Study of Tumor Treating Fields (TTFields, 150 kHz) Concomitant with Pembrolizumab and Platinum Based Chemotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer

Recruitment completed

Trial summary

To test the effectiveness and safety of TTFields, delivered using the NovoTTF-200T device, concomitant with pembrolizumab and platinum based chemotherapy in subjects with metastatic non-small cell lung cancer
(NSCLC)

Trial details

Short title

Lunar-2

Diagnosis

Lung cancer

Type of treatment

Medical Oncology

Phase

III

Investigators

Principal Investigators

Who can participate

Clinical trials can have restrictive criteria of who can and can’t participate, talk to your healthcare provider if you are interested in this clinical trial.